FDA Reviewing Risk With Off-Label Tramadol Use in ChildrenFDA Reviewing Risk With Off-Label Tramadol Use in Children

The FDA is investigating the risk for respiratory problems in children aged 17 years and younger treated with the pain medication tramadol. News Alerts
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news